undefined

Posts

undefined

Followers

User since undefined NaN
Indianapolis

Morning Checkup | Understanding which vaccines are most appropriate

By Janel Gordon,

2026-09-03

https://img.particlenews.com/image.php?url=1HS4e7_1EozEhYw00

Morning Checkup | Understanding vaccine guidelines

<fuel-video plugin-version="3.6" id="fuel-single-post-player" class="single-fuel-player" title="Morning Checkup | Understanding vaccine guidelines" video-url="https://fuel-streaming-prod01.fuelmedia.io/v1/sem/58165265-734d-4d4d-a23b-1aa5acb8715e.m3u8?swc=1bfd931a-0a27-48fa-928f-591d828ac7a9" data-poster-image="https://www.wishtv.com/wp-content/uploads/2026/09/03/2623786_thumbnail.png" data-audio-and-autoplay="1" preload="auto" data-swc="1bfd931a-0a27-48fa-928f-591d828ac7a9" data-channel="58165265-734d-4d4d-a23b-1aa5acb8715e"></fuel-video>" class="fuel_embeded_code_2623786">

INDIANAPOLIS (WISH) — As summer comes to a close and children settle into a new school year, many parents and adults are unsure where to turn for vaccine recommendations for the upcoming fall season.

By now, the Centers for Disease Control and Prevention’s (CDC) Advisory Council on Immunization Practices (ACIP) would have released their vaccine guidelines. As of now, no official guidelines have been released for Respiratory Syncytial Virus (RSV) or COVID-19 vaccines for 2026-2027.

The CDC states the influenza (flu) vaccine recommendations from July 2025 remain in effect for 2026-2027.

Many Americans depend on their health insurance and local pharmacy for vaccine coverage and administration; however, following the overhaul of ACIP last year and their recommendations for the 2025-2026 season, it may be unclear which vaccines are most appropriate and which ones are covered by insurance. Pharmacy availability may differ by state, with some requiring a prescription.

The American Medical Association and the Vaccine Integrity Project, based at the University of Minnesota’s Center for Infectious Disease Research and Policy (CIDRAP), collaborated on a comprehensive review of evidence for the 2026-2027 respiratory virus vaccine recommendations. Information regarding this process can be found here.

Below you will find links to recommendations based on this review from our nation’s leading medical organizations, including: the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, and the American Academy of Family Physicians.

Insurance companies should offer coverage for vaccines as of September 2025 through 2027.

Coverage may not include the new mRNA flu vaccine approved last month for individuals ages 50 years and above. All individuals, ages 6 months and above, should receive an annual flu vaccine. Children ages 6 months to 8 years of age, require 2 doses 4 weeks apart if they have never received a flu shot, only ever received one dose or have an unknown flu vaccine history.

Pregnant persons should avoid the intranasal flu vaccine as it is a live virus vaccine. For individuals 65 years and above, high-dose flu vaccine is recommended. Immunocompromised individuals should avoid the intranasal flu vaccine as well. Flu vaccine should be received by mid-October.

RSV is recommended for pregnant persons during the 3rd trimester (32-36 weeks of pregnancy) and given between September 1 and March 1, if no prior vaccination.

All infants less than 8 months who were born to a mother who did not receive a vaccine as above, should be vaccinated against RSV. Children 8-19 months, at high risk of severe RSV and entering their second RSV season, should be vaccinated. Adults 50 to 64 years of age at increased of severe RSV should receive a one-time RSV vaccine. All adults 75 years of age and above should receive a single dose of RSV.

COVID-19 vaccination should be administered to all children ages 6-23 months and children 2-18 years of age at increased risk of severe COVID-19  or whose parent or guardian desires their protection. All pregnant persons, adults ages 19-64 years, immunocompromised individuals ages 6 months and above and healthcare personnel should receive an annual COVID-19 vaccine. Adults ages 65 and above should receive an annual COVID-19 vaccine and a second dose 6 months later as protection can wane.

respiratory-virus-immunization-recommendationsDownload

Comments